Search Results 521-530 of 17182 for Jacobson

1. New Mast Cell Lines from Patients with Systemic Mastocytosis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Dr. Matthew Tollefson Archives - Mayo Clinic News Network

3. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

   The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

4. Jason Howland | Mayo Clinic News Network - Page 35 of 38

   A former TV news anchor and reporter for KAAL-TV, the ABC affiliate in Rochester, Minnesota, he has nearly 30 years of broadcast journalism experience. Jason ...

5. AsktheMayoMom about Proton Beam Therapy to Treat Children with Brain Tumors

   ... . VID-20381363. Home; AsktheMayoMom about Proton Beam Therapy to Treat Children with Brain Tumors. Fuel groundbreaking medical research!

6. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease - Mayo Clinic

   About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...

7. Tethered Capsule Endomicroscopy Surveillance of Barrett’s Esophagus Following Endoscopic Eradication Therapy - Mayo Clinic

   The purpose of this study is to explore the acceptability of tethered capsule endomicroscopy (TCE) for Barrett's Esophagus (BE) surveillance following CRIM. BE ...

8. Mayo Clinic Board of Trustees approves enabling projects for Bold. Forward. Unbound. in Rochester

   Media contact: Kristy Jacobson, Mayo Clinic Communications, newsbureau@mayo.edu · Ready to run: Post-race ...

9. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

   A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple ...

10. A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor ...